This HTML5 document contains 36 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n12http://linked.opendata.cz/resource/drugbank/drug/DB08480/identifier/pdb/
n9http://linked.opendata.cz/resource/drugbank/drug/DB08480/identifier/pubchem-compound/
n10http://linked.opendata.cz/resource/drugbank/drug/DB08480/identifier/pubchem-substance/
n11http://linked.opendata.cz/resource/drugbank/drug/DB08480/identifier/drugbank/
n4http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n14http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n5http://linked.opendata.cz/ontology/drugbank/
n13http://linked.opendata.cz/resource/drugbank/drug/DB08480/identifier/chemspider/
owlhttp://www.w3.org/2002/07/owl#
n6http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB08480
rdf:type
n5:Drug
n5:group
experimental
owl:sameAs
n4:DB08480 n14:DB08480
dcterms:title
4-HYDROXY-N-PROPARGYL-1(R)-AMINOINDAN
adms:identifier
n9:5494443 n10:99444951 n11:DB08480 n12:RM2 n13:4591891
n5:IUPAC-Name
n6:271B5C46-363D-11E5-9242-09173F13E4C5
n5:InChI
n6:271B5C4C-363D-11E5-9242-09173F13E4C5
n5:Molecular-Formula
n6:271B5C4B-363D-11E5-9242-09173F13E4C5
n5:Molecular-Weight
n6:271B5C48-363D-11E5-9242-09173F13E4C5
n5:Monoisotopic-Weight
n6:271B5C49-363D-11E5-9242-09173F13E4C5
n5:SMILES
n6:271B5C4A-363D-11E5-9242-09173F13E4C5
n5:Water-Solubility
n6:271B5C44-363D-11E5-9242-09173F13E4C5
n5:logP
n6:271B5C45-363D-11E5-9242-09173F13E4C5 n6:271B5C42-363D-11E5-9242-09173F13E4C5
n5:logS
n6:271B5C43-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Acceptor-Count
n6:271B5C52-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Donor-Count
n6:271B5C53-363D-11E5-9242-09173F13E4C5
n5:InChIKey
n6:271B5C4D-363D-11E5-9242-09173F13E4C5
n5:Polar-Surface-Area--PSA-
n6:271B5C4E-363D-11E5-9242-09173F13E4C5
n5:Polarizability
n6:271B5C50-363D-11E5-9242-09173F13E4C5
n5:Refractivity
n6:271B5C4F-363D-11E5-9242-09173F13E4C5
n5:Rotatable-Bond-Count
n6:271B5C51-363D-11E5-9242-09173F13E4C5
n5:Bioavailability
n6:271B5C58-363D-11E5-9242-09173F13E4C5
n5:Ghose-Filter
n6:271B5C5A-363D-11E5-9242-09173F13E4C5
n5:MDDR-Like-Rule
n6:271B5C5B-363D-11E5-9242-09173F13E4C5
n5:Number-of-Rings
n6:271B5C57-363D-11E5-9242-09173F13E4C5
n5:Physiological-Charge
n6:271B5C56-363D-11E5-9242-09173F13E4C5
n5:Rule-of-Five
n6:271B5C59-363D-11E5-9242-09173F13E4C5
n5:Traditional-IUPAC-Name
n6:271B5C47-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-acidic-
n6:271B5C54-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-basic-
n6:271B5C55-363D-11E5-9242-09173F13E4C5